Post by JHam on Nov 17, 2014 13:45:56 GMT
Pretty big deal between two big giants. Some people are worried that this news means neither Pfizer or Merck can be the partner for ONCS. Part of me thinks this just means both Pfizer and Merck will agree to partner with ONCS, and part of me thinks we can forget about ether of them being the partner, leaving basically BMY standing. We'll know soon enough:
www.marketwatch.com/story/pfizer-merck-strike-deal-to-develop-cancer-tumor-treatment-2014-11-17
"The exclusive nature of the deal means Pfizer and Merck cannot collaborate with any other drugmaker in the PD-LI or related PD-1 area, unless they jointly agree to do so."
www.marketwatch.com/story/pfizer-merck-strike-deal-to-develop-cancer-tumor-treatment-2014-11-17
"The exclusive nature of the deal means Pfizer and Merck cannot collaborate with any other drugmaker in the PD-LI or related PD-1 area, unless they jointly agree to do so."